[ Skip to Main Content ]
COVID-19: How We’re Responding

Media Center

@EngenderHealth a tenu à soutenir le @MinistereEnfant et toutes les organisations militantes pour les #droits des #femmes en #civ225 lors de l'offensive #orange ce samedi 4 décembre 2021

@CACi225
#OrangeTheWorld
#16JoursDactivismeIci

Today is Intl Day of Persons w/ Disabilities. More than 1 billion people are living with a disability. In Tanzania, we partnered w/ @CCBRTTanzania to ensure supported family planning activities are accessible. Learn more ➡️ http://bit.ly/3gYT6tj
#IDPD #EveryoneIncluded #CRPD

@EngenderHealth’s “Do No Harm” Framework informs @USAID_MOMENTUM’s work with partners in #DRC, #Nigeria, & #Mozambique to integrate #GBV screening into #fistula care. Read more about how this novel approach will keep women safe: http://usaidmomentum.org/making-the-connection-between-gender-based-violence-and-fistula-care

#MOMENTUMAgainstGBV

📣 We're #hiring an experienced Analyst, International Finance and Pricing, to oversee the financial & accounting management of our country offices & support the development & pricing & costing of proposals. Salary & benefits in posting. Apply now ➡️ http://ow.ly/7YFH50H2miT

On Dec. 3, EngenderHealth Country Representative for India Dr. Ajay Khera will participate in a #DigitalHealthWeek panel discussion on digitized Clinical Decision Support to assist frontline healthcare workers in Africa & Asia during COVID-19. Register ➡️ http://ow.ly/ZKSK50H1uf9

According to @UNAIDS, 37.7 million people were living with HIV in 2020. To end the epidemic, we need to focus on community-led solutions, provide equitable access to health services & ensure healthcare workers have training & resources to provide high-quality care. #WorldAIDSDay

Thank you for supporting us on #GivingTuesday! Your generosity will enable us to continue advancing sexual and reproductive health and rights and gender equality. If you couldn’t give yesterday, you can still make a difference by donating today ➡️ http://bit.ly/GivingTuesEH

Today is #GivingTuesday. We’re working with individuals & communities around the globe to make a gender-equal world a reality, but we can’t do it without your help!

Visit http://bit.ly/GivingTuesEH to donate & support this vital work.

We’re excited to introduce our 1st Youth Advisory Council in Ethiopia! The 15 volunteers, ages 14–24, will support youth access to SRH services, ensure #youth participation in projects & contribute youth perspectives to addressing #SRHR issues. #OrangeTheWorld #16Days #EndGBV

Aujourd'hui 24 novembre, veille de la commémoration des #16jours , marque la fin de l'atelier de formation des médias et blogueurs sur les #VBG. Nous tenons à remercier tous nos partenaires qui ont rendu cela possible.
@MinistereEnfant @UnfpaCI @ACF_CI @EngenderHealth @CACi225

Load More...
July 27, 2015

Innovative male circumcision device for HIV prevention receives World Health Organization prequalification

FOR IMMEDIATE RELEASE

Media Contacts:

EngenderHealth
Theresa Kim
tkim@engenderhealth.org
Tel: 646-808-6446
FHI 360:
Natasha Abel
nabel@fhi360.org
Tel: 202.884.8018
Weill Cornell Medical College:
Sarah Smith
sas2072@med.cornell.edu

Tel: 646.317.7401

June 24, 2015 — Washington, DC — The ShangRing, a novel medical device for voluntary medical male circumcision, has received prequalification from the World Health Organization (WHO) for use. The prequalification indicates that the ShangRing meets international standards of safety and has the potential to rapidly increase access to the device in sub-Saharan Africa and other regions where the burden of HIV is highest. Conclusive clinical research demonstrates that circumcision can reduce male acquisition of HIV through vaginal intercourse by up to 60 percent.

“This is a major milestone toward improving access to voluntary medical male circumcision, which will help to prevent HIV acquisition in low-resource settings and contribute to the international efforts to achieve an AIDS-free generation,” said Mr. Shang Jianzhong, inventor and board chairman of Wuhu Snnda Medical Treatment Appliance Technology Co., Ltd.

In 2007, WHO and the Joint United Nations Programme on HIV/AIDS (UNAIDS) recommended that voluntary medical male circumcision be included in HIV prevention programs in southern and eastern Africa, countries with high rates of heterosexually transmitted HIV and low rates of male circumcision. While WHO prequalification does not replace national regulatory approvals, it acts as a guide for many national health agencies and enables procurement of the device by programs such as the United States President’s Emergency Plan for AIDS Relief (PEPFAR).

The ShangRing is produced by Wuhu Snnda Medical Treatment Appliance Technology Co., Ltd of China. It consists of two concentric plastic rings that lock together over the foreskin. Unlike the conventional surgery, male circumcision with the ShangRing requires no sutures, involves minimal bleeding and is disposable. It is the first device prequalified by WHO for circumcision of both adults and adolescent boys ages 13 to 17 years.

“The ShangRing is very simple to use and reduces the time needed to perform male circumcision by about half, compared to conventional procedures,” says Jairus Oketch, Kenya Registered Community Health Nurse, Homa Bay District Hospital. “Expanded use of the device will enable countries to deliver safe, efficient, high-quality male circumcision to more people and thus reduce the spread of HIV.”

The ShangRing was assessed among more than 1,900 healthy adult men ages 18 years and older in five studies conducted in Kenya, Uganda and Zambia and among more than 350 adolescent males ages 13 to 17 years in Kenya and Uganda. The research in Kenya and Zambia was supported by a grant from the Bill & Melinda Gates Foundation to FHI 360 and conducted in collaboration with EngenderHealth, FHI 360 and Weill Cornell Medical College. The partners were instrumental in clinical research, provider training, inspection of the manufacturing facility and coordination with WHO.

About Wuhu Snnda Medical Treatment Appliance Technology Co., Ltd.

Wuhu Snnda Medical Treatment Appliance Technology Co., Ltd., is a cooperatively managed enterprise that manufactures Class II medical devices in accordance with the level of medical products classification. It was founded in June 2006 and is located in the Wuhu State-level Economic & Technological Development Zone. Visit www.snnda.com for additional information.

About EngenderHealth

EngenderHealth is a leading global women’s health organization committed to ensuring that every pregnancy is planned, every child is wanted, and every mother has the best chance at survival. In 20 countries around the world, we train health care professionals and partner with governments and communities to make high-quality family planning and sexual and reproductive health services available—today and for generations to come. Visitwww.engenderhealth.org for more information.

About FHI 360

FHI 360 is a nonprofit human development organization dedicated to improving lives in lasting ways by advancing integrated, locally driven solutions. Our staff includes experts in health, education, nutrition, environment, economic development, civil society, gender, youth, research, technology, communication and social marketing — creating a unique mix of capabilities to address today’s interrelated development challenges. FHI 360 serves more than 70 countries and all U.S. states and territories. For more information, visitfhi360.org.

About Weill Cornell Medical College

Weill Cornell Medical College, Cornell University’s medical school located in New York City, is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine, locally, nationally and globally. Physicians and scientists of Weill Cornell Medical College are engaged in cutting-edge research from bench to bedside, aimed at unlocking mysteries of the human body in health and sickness and toward developing new treatments and prevention strategies. In its commitment to global health and education, Weill Cornell has a strong presence in places such as Qatar, Tanzania, Haiti, Brazil, Austria and Turkey. Through the historic Weill Cornell Medical College in Qatar, the Medical College is the first in the U.S. to offer its M.D. degree overseas. Weill Cornell is the birthplace of many medical advances — including the development of the Pap test for cervical cancer, the synthesis of penicillin, the first successful embryo-biopsy pregnancy and birth in the U.S., the first clinical trial of gene therapy for Parkinson’s disease, and most recently, the world’s first successful use of deep brain stimulation to treat a minimally conscious brain-injured patient. Weill Cornell Medical College is affiliated with NewYork-Presbyterian Hospital, where its faculty provides comprehensive patient care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The Medical College is also affiliated with Houston Methodist. For more information, visit weill.cornell.edu.

Share this page: